NeuroOne Medical
NMTC
NeuroOne Medical (NMTC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Maxim Group | Maintained | Buy | $5.00 from $13.00 | Aug 14, 2026 |
| Ladenburg Thalmann | Maintained | Buy | $8.00 from $1.60 | May 13, 2026 |
| Jones Trading | Initiated Coverage | Buy | $1.50 | Mar 2, 2026 |
| Maxim Group | Initiated Coverage | Buy | $3.00 | Sep 9, 2025 |
| Ladenburg Thalmann | Initiated Coverage | Buy | $1.45 | May 5, 2025 |
| Alliance Global Partners | Maintained | Buy | $2.20 from $3.25 | Aug 15, 2023 |
Frequently asked questions
What is the latest analyst rating on NMTC?
On Aug 14, 2026, Maxim Group maintained NeuroOne Medical at Buy with a price target of $5.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.